Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation.
about
Autologous Graft-versus-Tumor Effect: Reality or Fiction?Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome.Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.Does chemotherapy modify the immune surveillance of hematological malignancies?Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.Biobehavioral influences on cancer progression.NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphomaEarly lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective studyCombination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come.Biobehavioral influences on recovery following hematopoietic stem cell transplantation.The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients.A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.Host immunity and survival.Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma.Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experienceAutograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantation.Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation.Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice.Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era.The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.Absolute lymphocyte count predicts overall survival in follicular lymphomas.Manual color monitoring to optimize hematopoietic progenitor cell collection on the Fenwal Amicus.Is Absolute Lymphocyte Count Just Another Prognostic Factor in Cancer?
P2860
Q28075459-9F40F0E2-BF01-46CE-8E7C-9CA7D300D975Q33383210-20B29C60-42C1-4F3E-8D03-5737D5336CC9Q33687086-01AAF251-FC04-4E39-A5CB-68CB83DA2008Q34223517-814BA90E-F97F-4F6E-A733-F17B33DC3EB0Q34388117-509B4A72-EF56-41E6-A5B7-C115687DDD0CQ34447713-3E74C899-A155-4490-B6AA-373DEF45C94BQ34485950-14BD8108-D55C-4AD7-BF31-46A0619410A3Q34652062-71EECE20-D085-4EB4-A865-8FEFC5FDF7C2Q35827808-7FD50D6A-EA5A-4D9E-81E2-70A2C70AD227Q36018407-501BD00E-1531-4368-BCA7-EFA8946C9B3CQ36331221-E304E0EC-7A5A-479A-A720-290AF9D5753AQ36385509-F1F0F75F-1A58-4989-82EA-4ED7E4D04F4EQ36546286-FBD709BA-FCAD-425B-9D2D-B3F861B310FCQ36813562-2F50F335-BCD8-4BFB-BBB3-2FD3A3A7B64AQ37157427-D899C532-9758-46CE-932D-14B64DE45A21Q37432037-D7D651E6-A45D-4066-86A2-7C84F1C918C6Q37772085-E1A0726E-C201-49A4-9711-8C83D28E88F5Q37878299-31625078-189B-4741-BF2E-05E17A825AD1Q38160461-54A1B135-0BDE-4A57-BE97-18AC5FE9F475Q38405199-75E4CC2A-EC65-4F6B-A772-DC8C74EE06DCQ38803570-37A1402C-0FB5-436F-80B0-FB91B5179199Q42591459-DE74CD07-0091-4421-BA01-A43FDFA9CD4FQ47258187-E41F7FFE-E5C6-470D-85FA-D0569A381B11Q52724284-40ABDB70-3061-4094-8CF4-1F661872FB35Q53005363-9D44DFF1-F3CF-4F6F-9B11-90E28B512F96Q53153100-45371303-552F-4256-BCE4-8999FE66E0D9Q53251809-18870048-8732-4677-8720-534A18AF5883Q53272403-5AF9CD65-1591-4232-83AF-70A10928FB25Q58650169-7F6FF0BC-77A6-4E9F-B3C8-13071B1CCE1D
P2860
Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Timely reconstitution of immun ...... ous stem cell transplantation.
@ast
Timely reconstitution of immun ...... ous stem cell transplantation.
@en
type
label
Timely reconstitution of immun ...... ous stem cell transplantation.
@ast
Timely reconstitution of immun ...... ous stem cell transplantation.
@en
prefLabel
Timely reconstitution of immun ...... ous stem cell transplantation.
@ast
Timely reconstitution of immun ...... ous stem cell transplantation.
@en
P1476
Timely reconstitution of immun ...... ous stem cell transplantation.
@en
P2093
Markovic SN
Porrata LF
P2888
P356
10.1007/S10238-004-0041-4
P577
2004-10-01T00:00:00Z